<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Philouze P</submitter><funding>National League Against Cancer</funding><funding>LabEx PRIMES</funding><funding>Nuovo-Soldati Research Foundation</funding><funding>French National Research Agency</funding><pagination>102595</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12630086</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>63</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Non-HPV-induced squamous cell carcinomas (SCC) of the oropharynx have a poorer prognosis than HPV-induced cancers because they are more radio- and chemoresistant. Currently, no predictive biomarker exists for survival outcome in this type of tumor. NRF2 is a nuclear transcription factor that regulates the expression of cytoprotective genes, and peroxiredoxin 6 is one of the proteins regulated by NRF2. Both are potentially involved in the resistance to treatments as they play a central role in the response to oxidative stress.&lt;h4>Material and methods&lt;/h4>In a retrospective cohort study of 53 patients with advanced HPV-negative squamous cell carcinomas of the oropharynx, we studied the correlation between clinical characteristics, response to treatment (surgery + radiother</pubmed_abstract><journal>Translational oncology</journal><pubmed_title>Nuclear factor E2 p45-related factor (NRF2) and peroxiredoxin 6 tissular expression as prognostic biomarkers for advanced HPV-negative squamous cell carcinoma of the oropharynx.</pubmed_title><pmcid>PMC12630086</pmcid><funding_grant_id>ANR-11-LABX-0063</funding_grant_id><funding_grant_id>ANR-11-IDEX-0007</funding_grant_id><pubmed_authors>Benzerdjeb N</pubmed_authors><pubmed_authors>Kobler A</pubmed_authors><pubmed_authors>Ceruse P</pubmed_authors><pubmed_authors>Alphonse G</pubmed_authors><pubmed_authors>Burgy M</pubmed_authors><pubmed_authors>Soumboundou M</pubmed_authors><pubmed_authors>Wozny AS</pubmed_authors><pubmed_authors>Philouze P</pubmed_authors><pubmed_authors>Malesys C</pubmed_authors><pubmed_authors>Rodriguez-Lafrasse C</pubmed_authors><pubmed_authors>Jung AC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nuclear factor E2 p45-related factor (NRF2) and peroxiredoxin 6 tissular expression as prognostic biomarkers for advanced HPV-negative squamous cell carcinoma of the oropharynx.</name><description>&lt;h4>Objectives&lt;/h4>Non-HPV-induced squamous cell carcinomas (SCC) of the oropharynx have a poorer prognosis than HPV-induced cancers because they are more radio- and chemoresistant. Currently, no predictive biomarker exists for survival outcome in this type of tumor. NRF2 is a nuclear transcription factor that regulates the expression of cytoprotective genes, and peroxiredoxin 6 is one of the proteins regulated by NRF2. Both are potentially involved in the resistance to treatments as they play a central role in the response to oxidative stress.&lt;h4>Material and methods&lt;/h4>In a retrospective cohort study of 53 patients with advanced HPV-negative squamous cell carcinomas of the oropharynx, we studied the correlation between clinical characteristics, response to treatment (surgery + radiother</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T17:35:51.568Z</modification><creation>2026-05-19T03:12:05.208Z</creation></dates><accession>S-EPMC12630086</accession><cross_references><pubmed>41187427</pubmed><doi>10.1016/j.tranon.2025.102595</doi></cross_references></HashMap>